Aurora Cannabis Inc. (TSXV: ACB) (OTCQX: ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) is pleased to announce that today the Company will be hosting a delegation from Australia , led by the Honourable Jaala Pulford, Minister of Agriculture and Minister for Regional Development for the State of Victoria.
A better than expected quarter has Clarus analyst Noel Atkinson raising his price target on Aphria (TSXV:APH).
On Wednesday, Aphria reported its Q4 and fiscal 2017 results. In the fourth quarter, the company lost $2.6-million on revenue of $5.7-million, a topline that was up 106 per cent over the same period last year.
The Company expects to benefit from being listed on the OTCQB and the FSE by gaining greater visibility and convenience of trading the Company’s common shares to US and European investors, allowing a much larger potential shareholder base and enhanced liquidity.
ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) this morning announced that its common shares have been approved for trading on the OTCQB Venture Market, under the symbol ‘ABCCF’, and on the Frankfurt Stock Exchange, under the symbol ‘23Q’.
CURE Pharmaceutical (OTCQB:CURR), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company and Therapix Biosciences (Nasdaq: TRPX ), a specialty clinical-stage pharmaceutical company dedicated to the development of cannabinoid-based drugs headquartered in Israel, announced today that they signed a memorandum of understanding (MOU) to enter into a research collaboration with Assuta Medical Centers Ltd.
Strainprint, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg , Dr. Sana-Ara Ahmed , and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the second quarter of 2017 generated the largest revenue quarter in the Company's history. Additionally, the Company celebrated the largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway.
ABcann Global Corporation (TSX: ABCN ) and Cannabis Wheaton Income Corp. (TSX: CBW) are pleased to announce the signing of a definitive subscription agreement pursuant to which CW has agreed to purchase $15 million of ABcann common shares at $2.25 per share.
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a research and development collaboration with ATERA SAS of France, a leading tissue engineering company specializing in the development of advanced human tissue models.
ABcann Global Corporation (TSXV: ABCN) this morning announced the signing of a definitive subscription agreement with Cannabis Wheaton Income Corp. (TSXV: CBW).
Per the update, consumers who buy hemp-based products, foods and beverages from the ChineseHempOil.com site will have the option to pay with bitcoin, in addition to more common payment methods such as debit cards and PayPal.
The history of cannabis in Canada has been a tumultuous journey. We're taking a closer look at the complex road from prohibition to legalization.
The post The History of Cannabis in Canada appeared first on Leafly.
Marijuana stocks are flying high right now. There’s no reason to think that 2017 won’t be yet another great year, right? Actually, some significant threats remain for the now-thriving marijuana industry. Here are three of the biggest risks for marijuana stocks this year.
ABcann Global Corporation (TSXV: ABCN) yesterday announced its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ). The ETF is a first-of-its-kind index offering investors direct exposure to a basket of North American life sciences companies with significant business activities in the medical marijuana sector.
Cytori Therapeutics (NASDAQ: CYTX) this morning said it has received key patents that strengthen its intellectual property portfolio in the U.S. and Europe, sending shares up 2% mid-morning.
